Ultragenyx Pharmaceutical Company
Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.
Investors
Headquarters:
Novato, California, United States
Founded Date:
2010
Technology:
Immunotherapy
Estimated Revenue:
$10M to $50M
Industry:
PharmTech
Funding Status:
IPO
Employee Number:
501-1000








%20.jpg)





%20.jpg)


